📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

Controversial issues in the neoadjuvant treatment of triple-negative breast cancer (2019)

First Author: Fitzpatrick A

Attributed to: Identifying molecular drivers and early diagnostic biomarkers in breast cancer leptomeningeal metastasis by the interrogation of cerebrospinal fluid funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1177/1758835919882581

PubMed Identifier: 31700549

Publication URI: http://europepmc.org/abstract/MED/31700549

Type: Journal Article/Review

Parent Publication: Therapeutic Advances in Medical Oncology

ISSN: 1758-8340